Venture Capital News Daily
   Your Source for Venture Capital and Private Equity Financings
   Massinvestor/VC News Daily      
   Venture Capital News Daily on RSS Venture Capital News Daily on Facebook Venture Capital News Daily on Twitter
VC DATABASE   /   MOBILE APP  /  CELEBRITY VCs   /   VENTURE TRACKR   /   ARCHIVE   /   ABOUT US
VC-funded Company:


Quentis Therapeutics
430 E 29th St., Suite 1005
New York, NY 10016
Phone: 646-440-9249
http://www.quentistx.com/

Quentis Therapeutics is a preclinical stage biotechnology company that is translating novel biology into new therapeutic approaches to help more cancer patients benefit from immunotherapy. Based on our deep expertise in endoplasmic reticulum (ER) stress biology and the tumor microenvironment, we are pioneering first-in-class ER stress response modulators to boost the immune system's ability to fight cancer. Our lead program is a first-in-class IRE1a inhibitor. We are pursuing multiple additional ER stress pathway targets in the tumor micro-environment, as well as in other diseases where ER stress plays an important role.

Key Contact
NameTitleE-Mail
Michael AbermanCEOmichael@quentistx.com


Funding Events
DateAmountTypeInvestors
02/28/18$48,000,000Series A AbbVie Biotech Ventures
Alexandria Real Estate Equities
New York Ventures
Polaris Venture Partners  
Taiho Ventures
Versant Ventures  
Yonghua Capital
 
Massinvestor/VC News Daily
617-620-4606


© 2018 Massinvestor, Inc.